Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update ; volume:22 ; number:1 ; day:28 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Thrombosis journal ; 22, Heft 1 (28.5.2024), 1-12, 12.2024
- Creator
-
Maghsudlu, Mohaddese
Noroozi, Zahra
Zokaei, Elham
Motevaseli, Elahe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-024-00612-9
- URN
-
urn:nbn:de:101:1-2408060953344.451732284218
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maghsudlu, Mohaddese
- Noroozi, Zahra
- Zokaei, Elham
- Motevaseli, Elahe
- SpringerLink (Online service)
Other Objects (12)
Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
P2.03 The Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphism Affects Central Arterial Blood Pressure in Women
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Towards secure 4G and 5G access network protocols
Der 4G/5G-PAI-1-Polymorphismus beim primären Mammakarzinom
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung des 4G/5G-PAI-1-Promotorpolymorphismus beim Ovarialkarzinom
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
P2.03 The Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphism Affects Central Arterial Blood Pressure in Women
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Towards secure 4G and 5G access network protocols
Der 4G/5G-PAI-1-Polymorphismus beim primären Mammakarzinom
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung des 4G/5G-PAI-1-Promotorpolymorphismus beim Ovarialkarzinom
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
P2.03 The Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphism Affects Central Arterial Blood Pressure in Women
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Towards secure 4G and 5G access network protocols
Der 4G/5G-PAI-1-Polymorphismus beim primären Mammakarzinom
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung des 4G/5G-PAI-1-Promotorpolymorphismus beim Ovarialkarzinom